Most Popular in the last 30 days

Boston Scientific's Resonate ICD, CRT-D systems gain FDA approval

Study: Blood test identifies patients with advanced prostate cancer likely to respond to targeted treatments

Boston Scientific posts higher first-quarter sales, profit

LabCorp's first-quarter sales, profit increase; lowers annual outlook